Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


One In Five Women Would Consider Breast Removal To Reduce Their Risk Of Cancer


A new international survey – connected to a study taking place at the University of Dundee - reveals that around one in five women would consider having both breasts removed to help reduce their risk of developing breast cancer if told they were at an increased risk of developing the disease.

The survey asked over 1500 women from around the world what choices they would make if told they were at high risk of developing breast cancer. Of the UK women who were questioned, up to one in three said they would consider having a double mastectomy.

Breast cancer experts wanted to learn more about women’s attitudes to breast cancer worldwide as they take the first step in trying to prevent up to 80 per cent of hormone sensitive breast cancers. With nearly half the women saying they were concerned about developing breast cancer, the study highlights the need for all prevention options, particularly new ones, to be clearly explained. Women in the UK are particularly worried with around 60 per cent saying they are concerned about breast cancer.

When asked if they would consider taking part in a trial investigating a preventive treatment for breast cancer, around 50 per cent of the women said they would consider it. Around 45 per cent of the women in the survey said they would consider taking a daily tablet as a preventive step against breast cancer.

In the UK there are around 41,000 women diagnosed with breast cancer every year. Around 80 per cent of these are post-menopausal women.

Scientists based at the University of Dundee are involved in one of the first worldwide prevention trials, called IBIS-II1, which is investigating whether a drug already used to treat breast cancer may have the ability to prevent the disease.

This landmark trial involves postmenopausal, high risk women taking a once-a-day pill containing the drug anastrozole. Previous trials investigating this drug as a treatment for breast cancer have shown that it reduces the risk of developing cancer in the opposite breast by over 50 per cent2.

The female hormone, oestrogen, is known to be the most important cause of breast cancer in post-menopausal women and anastrozole works by stopping oestrogen being produced.

This is the first time the drug is being investigated as a preventive measure. Cancer Research UK scientists are looking for 6,000 women from around the world to take part in the trial.

“The IBIS-II study is extremely important for women with an increased risk of developing breast cancer” commented Professor Jack Cuzick, Cancer Research UK’s lead researcher on the trial. “It is vitally important that women come forward to participate in the trial. It could provide them with a valuable option in helping to control breast cancer. Many of us already take medications to prevent heart disease so just imagine the possibilities if, in the future, we could use a simple, once-a-day medication, to reduce the occurrence of breast cancer. For those women faced with the reality of being at high risk of developing breast cancer, this trial has the potential to change their lives.”

He adds: “With over 30,000 post-menopausal women being diagnosed with breast cancer in the UK every year, i t’s vital that we look for effective ways of preventing the disease.”

Dr Lesley Walker, Director of Cancer Information at Cancer Research UK, says: “It is extremely rare for women to undergo a double mastectomy for preventive reasons and as an option, it is most relevant to women with a very strong family history of breast cancer. The global launch of IBIS-II aims to provide women with a new, far less radical option for preventing breast cancer at a time when numbers of women being diagnosed with the disease and concern about it, is so high. Through trials like this, women and researchers are working together to help discover clear and safe options for helping to prevent breast cancer.”

Professor Alastair Thompson, Professor of Surgical Oncology at Ninewells Hospital and Medical School, is the local trial co-ordinator in Dundee. He said, “We urge all women who are concerned about breast cancer to speak with their doctor. Understanding your risk of developing breast cancer and knowing what options are available are essential for all women. We are asking those women who are eligible for the trial to come forward and help us to find a way to help prevent breast cancer.”

To be eligible to take part in the IBIS II programme, women must be post-menopausal, not taking HRT and have at least twice the normal risk of breast cancer – for example someone whose mother or sister had breast cancer before the age of 50, or who has two family members with the disease.

Post-menopausal women who are interested in taking part should contact research nurses Gillian Little and Mhairi Hawkes on 01382 633850.

Roddy Isles | alfa
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>